Levbid Drug Uses

Levbid is used to control conditions such as excessive stomach acid production, excessive secretion from the pancreas, and excessive sweating and drooling associated with diseases like Parkinson's disease.

How Taken

Take each dose with a full glass of water. Do not crush, chew, or open the capsules. Swallow them whole. The capsules are specially formulated to release slowly in your body.

Levbid Warnings/Precautions

Before taking this medication, tell your doctor if you have: numbness or tingling in your hands or feet; liver disease; ulcerative colitis; thyroid problems; high blood pressure, an irregular heartbeat, or any type of heart disease; enlargement of the prostate; or asthma, chronic lung disease, or allergies. You may not be able to take Levbid, or you may require a lower dose or special monitoring during treatment if you have any of the conditions listed above. It is not known whether Levbid will harm an unborn baby. Do not take this medicine without first talking to your doctor if you are pregnant or breast-feeding.

Levbid Missed Dose

Take the missed dose as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and take only the next regularly scheduled dose. Do not take a double dose of this medication.

Levbid Possible Side Effects

If you experience any of the following serious side effects, stop taking Levbid and seek emergency medical attention: an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives); an irregular or fast heart rate; rash or flushing; or eye pain. Other, less serious side effects may be more likely to occur. Continue to take Levbid and talk to your doctor if you experience: headache, dizziness, or lightheadedness; weakness or nervousness; blurred vision, large pupils, or sensitivity of the eyes to bright light; nausea, bloating, heartburn, or constipation; changes in taste.

Levbid Storage

Store Levbid at room temperature away from moisture and heat. Keep out of the reach of children.

Levbid Overdose

Seek emergency medical attention in case of overdose. Symptoms of a Levbid overdose include headache; nausea; vomiting; dry mouth; difficulty swallowing; blurred vision; dilated pupils; hot, dry skin; dizziness; drowsiness; confusion; anxiety; seizures; weak pulse; and an irregular heartbeat.

More Information

Use caution when driving, operating machinery, or performing other hazardous activities. This medicine may cause dizziness, drowsiness, or blurred vision. If you experience dizziness, drowsiness or blurred vision, avoid these activities.

Disclaimer

This drug information is for your information purposes only, it is not intended that this information covers all uses, directions, drug interactions, precautions, or adverse effects of your medication. This is only general information, and should not be relied on for any purpose. It should not be construed as containing specific instructions for any particular patient. We disclaim all responsibility for the accuracy and reliability of this information, and/or any consequences arising from the use of this information, including damage or adverse consequences to persons or property, however such damages or consequences arise. No warranty, either expressed or implied, is made in regards to this information.

---

While you're visiting Medspharmacy-online.com escrow service you should browse around and find out what other medications are available other than just Viagra. Medspharmacy-online.com will provide you with great products like Viagra and excellent customer service.

You will see there is almost every popular medication available both online and at a great saving to you. The discount prices alone can't be beat on Viagra and the process is painless. Try Medspharmacy-online.com escrow service out and you will see why the existing customers have come back over and over.

Medspharmacy-online.com offers safe, secure and fast online payment because we are concerned about the safety and security of our customers. Accordingly, we have put a number of technological protections in place to ensure that our transaction process is extremely safe and that our customers' information is secure.

Cost-conscious seniors seeking the lowest cost medicines need not battle holiday shoppers looking to take advantage of a price promotion. Low-cost drugs can be found at Medspharmacy-online.com, which offers more drugs at a lower cost than even the most-widely touted superstore's retail pricing promotion.

Medspharmacy-online.com provides access to ten times the number of medicines currently available through the limited pricing promotions marketed by the largest retail superstores and drug chains. No waiting, no lines and no ugly surprises.


Q: What is your cancellation policy for Levbid?
A: You may cancel your order before the order has shipped or been approved by the doctor. If the order has already been shipped or approved we cannot cancel your order. Please refer to the current cancellation policy in the terms & conditions section of our order page for more information.


July 24, 2007 -- An expert panel gave its OK for expanded use of the osteoporosis drug Evista Tuesday, telling the FDA that the drug appears effective in preventing some breast cancer.
If the agency follows the panel's advice, it would clear the way for the drug, also called raloxifene, to be legally sold as a cancer prevention agent to millions of women.
It would also position the drug as an alternative to the anti-estrogen drug tamoxifen, which has long been used to help fight breast cancer's return. In 1998, the FDA approved tamoxifen for use by women who hadn't had breast cancer but were at high risk of developing the disease.
Breast cancer is the second leading cause of cancer death among women, and about 40,500 American women will die from breast cancer in 2007, according to the American Cancer Society. About 13% of women are estimated to develop breast cancer in their lifetime, according to the National Cancer Institute.
"Postmenopausal women at high risk for invasive breast cancer, I think now should have a choice," says George Sledge, MD, a professor of medicine at Indiana University. Sledge is also a consultant for Eli Lilly & Co, the maker of Evista.
Experts voted 10-4, with one abstaining, to recommend that Lilly be allowed to market Evista's ability to cut the likelihood of breast cancer in postmenopausal women at high risk for tumors. A company study showed that raloxifene and tamoxifen are equally effective at reducing the risk of cancer in those women.
"I do believe raloxifene is effective in reducing breast cancer," says panelist Otis Brawley, MD, a professor of oncology at Emory University School of Medicine.
Close Decision
The panel voted 8 to 6, with one abstention, on whether Lilly should be allowed to promote Evista's possible cancer-fighting abilities to all postmenopausal women with osteoporosis.
Three studies filed by the company all showed that women who took Evista for up to five years developed fewer invasive breast cancers than women who took a placebo. But women who took the drug also had a higher risk of serious blood clots and fatal stroke.
An FDA analysis of the three studies was inconclusive as to whether Evista's potential benefits outweighed its risks. Agency officials said they were troubled because Lilly had not submitted any data showing whether women who take Evista actually live longer than those who don't.
"It is uncertain if the balance of benefits and risk factors for women at high risk is favorable because the magnitude of benefits is unknown," says Patricia Cortazar, MD, an FDA safety official.
Potential Risks
Several breast cancer advocacy groups opposed the approval. Carolina Hinestrosa, executive vice president of the Breast Cancer Coalition, says the government should boost efforts to find causes of breast cancer rather than approving drugs with relatively small benefits.
"Considering that most women will not develop breast cancer in their lifetimes ... taking raloxifene and tamoxifen as a risk reduction measure will be unnecessary for most," she says.
Some panelists urged the FDA to restrict the drug's marketing, particularly to keep it out of the hands of women at risk for cardiovascular disease. One panelist even suggested issuing a "black box" warning for Evista.
"There should be a strong effort to limit potential harm," says Curt D. Furburg, MD, a Wake Forest University professor of public health who voted to approve the new use for Evista.
Lilly paid $36 million in fines in 2005 after pleading guilty to illegally promoting Evista as a cancer-fighting drug. Critics said approving the new use for the drug would clear the way for the company to promote the drug with direct-to-consumer advertising.
Gwen Krivi, PhD, vice president of Lilly Research Laboratories, says the company will "continue working with the FDA to make this important option a reality for patients."

Frequent Levbid misspellings: kevbid, pevbid, oevbid, lwvbid, lsvbid, ldvbid, lrvbid, l4vbid, l3vbid, lecbid, lebbid, legbid, lefbid, levvid, levnid, levhid, levgid, levbud, levbjd, levbkd, levbod, levb9d, levb8d, levbis, levbix, levbic, levbif, levbir, levbie, evbid, lvbid, lebid, levid, levbd, levbi, elvbid, lvebid, lebvid, levibd, levbdi, llevbid, leevbid, levvbid, levbbid, levbiid, levbidd

Levbid search phrases: Levbid online, Levbid overnight delivery, Levbid no prescription, Levbid rx, Levbid uses, Levbid generic, Levbid prescription, Levbid overdose, Levbid brand name, Levbid order